Q4 report Thursday, 30 January at 07:00 CET '24e-'26e EBITA up 0-3%; 8% CAGR '23-'26e 11-9x EBITA '2...
De underliggande portföljbolagen fortsätter att utvecklas väl och väntas växa omsättning respektive ...
Redeye comments on Truecaller ahead of its Q4 results, which are due on 18 February.
Q3 figures below due to maintenance on Brage Løvmeis plugged and abandoned, Bounty next We reiterate...
Q4 report postponed to 28 March due to rights issue Preliminary Q4 figures to be published around 27...
Strong deliveries in Q4, sales +32% vs cons, EBIT +70% Guides for strong sales and order intake in 2...
Redeye comments on Thunderful Group ahead of its Q4 results, due on 13 February.
AVTECH published preliminary figures for Q4 2024, which showed net sales increased 22% y/y, with EBI...
Q4e sales of SEK 23.9m, down 14% y-o-y, EBIT SEK -7m (-6m) NW&FT and FW weak while momentum continue...
Q4e sales SEK 50m, flat y-o-y, EBIT SEK -0.6m (-2.1m) Somewhat more cautious on Perf.
Redeye comments on Invisio’s preannounced figures for Q4 which were much stronger than expected.
This afternoon, Føroya Banki raised its 2024 net profit guidance to DKK 302-312m (previously DKK 275...
Mangold inleder bevakning av medicinteknikbolaget PolarCool.
EE headwinds from programme end-of-life and automotive market Mix effects and major FX revaluations ...
Vi inleder bevakning på Xoma, en svensk teknikleverantör som utvecklar landbaserade system för algod...
Redeye provides its thoughts on the rights issue.
The recent acquisition of Norwegian point-of-care diagnostics platform SpinChip by bioMérieux for EU...
Redeye expects Smart Eye’s Q4 report, due 18 February, to show a 4% y/y sales growth and an EBITDA i...
Redeye is very pleased to see that OXE Marine has received another major order from the US Governmen...
Strong Q4 with a beat on all headline items... ...adds more fuel to '25e growth: guidance remains to...
